CPD |
CPD: Carboxypeptidase D precursor |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
2.895 |
Evidence |
|
TMSL8 |
TMSL8, TMSNB: NB thymosin beta |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
2.895 |
Evidence |
|
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
2.895 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NR5A1 |
NR5A1, AD4BP, FTZF1, SF1: Steroidogenic factor 1 |
2.895 |
Evidence |
|
SLPI |
SLPI, WAP4, WFDC4: Antileukoproteinase precursor |
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
2.895 |
Evidence |
|
PLD2 |
PLD2: Phospholipase D2 |
S100A11 |
MLN70, S100A11, S100C: Protein S100-A11 |
2.895 |
Evidence |
|
HSF1 |
HSF1, HSTF1: Heat shock factor protein 1 |
GAB1 |
GAB1: GRB2-associated-binding protein 1 |
2.895 |
Evidence |
|
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
HDAC2 |
HDAC2: Histone deacetylase 2 |
2.895 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
2.895 |
Evidence |
|
IL2RA |
IL2RA: Interleukin-2 receptor alpha chain precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
2.895 |
Evidence |
|
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
2.895 |
Evidence |
|
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
2.895 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
NR4A1 |
CDNA FLJ16818 fis, clone TRACH1000193, highly similar to Orphan nuclear receptor |
2.895 |
Evidence |
|
IL5 |
IL5: Interleukin-5 precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
2.895 |
Evidence |
|
FRS3 |
FRS3: Fibroblast growth factor receptor substrate 3 |
CHUK |
IPI00556043 |
2.895 |
Evidence |
|
DLG1 |
IPI00218729 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
2.895 |
Evidence |
|
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
2.895 |
Evidence |
|
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
HMGA2 |
HMGA2, HMGIC: High mobility group protein HMGI-C |
2.895 |
Evidence |
|
FGA |
IPI00021885 |
PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
2.895 |
Evidence |
|
MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
CFL1 |
CFL1, CFL: Cofilin-1 |
2.895 |
Evidence |
|
AGRP |
AGRP, AGRT, ART: Agouti-related protein precursor |
FGA |
IPI00021885 |
2.895 |
Evidence |
|
NEK3 |
NEK3: Serine/threonine-protein kinase Nek3 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
2.895 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
2.895 |
Evidence |
|
CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
2.895 |
Evidence |
|
PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
DLG1 |
IPI00218729 |
2.895 |
Evidence |
|